The bioenergetics of COVID-19 immunopathology and the therapeutic potential of biophysical radiances

被引:6
|
作者
Surazakov, Arzhan [1 ]
Klassen, Anna [2 ]
Gizinger, Oksana [3 ]
机构
[1] Radiant Life Technol Ltd, 10 Chalkokondyli St,Amaral 7,Off 101, CY-1071 Nicosia, Cyprus
[2] Valdayskaya 73, Barnaul 656901, Russia
[3] RUDN Univ, Dept Microbiol & Virol, Dept Immunol & Allergol, Inst Med, Moscow, Russia
关键词
COVID-19; Bioenergetics; Low level infrared laser; Magnetic field; Ultrasound; Photobiomodulation; coMra; INTENSITY PULSED ULTRASOUND; LEVEL LASER THERAPY; HE-NE-LASER; ATP SYNTHESIS; IN-VITRO; IRRADIATION; INFLAMMATION; CELLS; CHEMISTRY; LIGHT;
D O I
10.1016/j.jphotobiol.2020.112083
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In developing an effective clinical tool against COVID-19, we need to consider why SARS-CoV-2 infections develop along remarkably different trajectories: from completely asymptomatic to a severe course of disease. In this paper we hypothesize that the progressive exhaustion and loss of lymphocytes associated with severe stages of COVID-19 result from an intracellular energy deficit in an organism which has already been depleted by preexisting chronic diseases, acute psychological stress and the aging process. A bioenergetics view of COVID-19 immunopathology opens a new biophysical opportunity to enhance impaired immune function via proposed pathways of photomagnetic catalysis of ATP synthesis, regenerative photobiomodulation and the ultrasonic acceleration of cell restructuring. Moreover, we suggest that a coherent application of multiple biophysical radiances (coMra) may synergistically enhance energy-matter-information kinetics of basal self-regeneration of cells and thus improve immune function and accelerate recovery.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Evaluation of Potential Therapeutic Options for COVID-19
    Austin, Daren
    Okour, Malek
    JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (08): : 976 - 977
  • [22] Potential therapeutic effects of Ivermectin in COVID-19
    Barati, Nastaran
    Motavallihaghi, Seyedmousa
    Nikfar, Banafsheh
    Chaichian, Shahla
    Momtazi-Borojeni, Amir Abbas
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 247 (15) : 1388 - 1396
  • [23] Naltrexone a potential therapeutic candidate for COVID-19
    Choubey, Abhinav
    Dehury, Budheswar
    Kumar, Sunil
    Medhi, Bikash
    Mondal, Prosenjit
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (03): : 963 - 970
  • [24] COVID-19: immunopathology and its implications for therapy
    Xuetao Cao
    Nature Reviews Immunology, 2020, 20 : 269 - 270
  • [25] A mouse model of COVID-19 associated immunopathology
    Pimenov, Lisabeth
    Gawish, Riem
    Starkl, Philipp
    Hladik, Anastasiya
    Lakovits, Karin
    Repic, Anna Ohradanova
    Oostenbrink, Chris
    Agerer, Benedikt
    Bergthaler, Andreas
    Knapp, Sylvia
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 349 - 349
  • [26] COVID-19: immunopathology and its implications for therapy
    Cao, Xuetao
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (05) : 269 - 270
  • [27] On the Alert for Cytokine Storm: Immunopathology in COVID-19
    Henderson, Lauren A.
    Canna, Scott W.
    Schulert, Grant S.
    Volpi, Stefano
    Lee, Pui Y.
    Kernan, Kate F.
    Caricchio, Roberto
    Mahmud, Shawn
    Hazen, Melissa M.
    Halyabar, Olha
    Hoyt, Kacie J.
    Han, Joseph
    Grom, Alexei A.
    Gattorno, Marco
    Ravelli, Angelo
    De Benedetti, Fabrizio
    Behrens, Edward M.
    Cron, Randy Q.
    Nigrovic, Peter A.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (07) : 1059 - 1063
  • [28] COVID-19: Transmission, prevention, and potential therapeutic opportunities
    Lotfi, Melika
    Hamblin, Michael R.
    Rezaei, Nima
    CLINICA CHIMICA ACTA, 2020, 508 : 254 - 266
  • [29] Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients
    Aliter, Kholoud F.
    Al-Horani, Rami A.
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (06) : 866 - 875
  • [30] COVID-19: Oxidative Preconditioning as a Potential Therapeutic Approach
    Akki, Rachid
    Fath, Nada
    Mohti, Hicham
    ACS CHEMICAL NEUROSCIENCE, 2020, 11 (22): : 3732 - 3740